circadian rhythm raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-03-31 and is reviewed periodically as new material appears.
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
SR9009 is a synthetic small molecule developed as an agonist of the nuclear receptors REV-ERBα (NR1D1) and REV-ERBβ (NR1D2). These receptors help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, SR9009 alters transcription of genes involved in lipid metabolism, inflammation, and mitochondrial function. It is not an approved medicine, and its pharmacological profile in humans remains largely uncharacterized. The compound is frequently discussed in the context of circadian biology and metabolic research rather than clinical use.
Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Common supplier description |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water |
| Typical storage | −20 °C, desiccated, dark | For research samples |
| Analytical method | LC-MS/MS | Used for detection and quantification |
| Regulatory status | Prohibited in sport | WADA metabolic modulator class |
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ, also called NR1D1 and NR1D2. These receptors help regulate circadian rhythms and metabolic gene programs. The compound was developed for laboratory research, not as an approved therapeutic. Its identity is distinct from steroid hormones and selective androgen receptor modulators. Scientific interest centers on how REV-ERB activation changes gene expression in cells and animal models.
At the molecular level, SR9009 binds the ligand-binding domain of REV-ERB and strengthens recruitment of corepressor proteins such as NCoR and HDAC3. This increases repression of target genes, including Bmal1 and other clock-controlled and metabolic genes. In rodent studies, such changes have been linked to altered lipid handling, glucose metabolism, and energy expenditure. The precise chain of events between receptor binding and whole-body effects remains an active area of research. Findings in animals do not automatically translate to humans.
Laboratory studies often administer SR9009 by injection because oral absorption appears poor in rodents. Reported pharmacokinetic properties include rapid metabolism and low systemic exposure after oral dosing. Human pharmacokinetic data are sparse, so absorption, distribution, metabolism, and excretion in people are not well defined. Some research explores related REV-ERB compounds with improved drug-like properties. Regulatory approval for any REV-ERB agonist as a human medicine has not been granted to date.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
=== Irritable bowel syndrome === There is evidence that a dietician-supervised low-FODMAP diet is the best available way to control IBS symptoms, though there is a lack of evidence on possible adverse effects. The beneficial effect of low-FODMAP for people with IBS may be related to reduced osmotic load in the gut or changes in gut-brain axis signaling. The low-FODMAP diet does not cause any significant change in the gut microbiota in people with IBS. The effectiveness of low-FODMAP diet in children with IBS is unclear. While restrictive diets like the low-FODMAP diet can help manage symptoms in patients with Irritable bowel syndrome, they pose a significant danger: they can increase the patient's risk of developing disordered eating. The initial success in symptom reduction may become a dangerous obsession with controlling food, potentially leading to conditions such as ARFID or Orthorexia nervosa. These issues severely impact clinical outcomes and quality of life, and worsen overall health. Early monitoring and intervention are crucial to catching and addressing these pathological eating patterns.
THAP, DHAP, and a mixture of 2-aza-2-thiothymine and phenylhydrazine have been identified as matrices that could be used to minimize loss of sialic acid during MALDI MS analysis of glycosylated peptides. It has been reported that a reduction in loss of some post-translational modifications can be accomplished if IR MALDI is used instead of UV MALDI. Besides proteins, MALDI-TOF has also been applied to study lipids. For example, it has been applied to study the catalytic reactions of phospholipases. In addition to lipids, oligonucleotides have also been characterised by MALDI-TOF. For example, in molecular biology, a mixture of 5-methoxysalicylic acid and spermine can be used as a matrix for oligonucleotides analysis in MALDI mass spectrometry, for instance after oligonucleotide synthesis.
== Structure == The catalytic peptide of ALS in Arabidopsis thaliana (mouse-eared cress) is a chloroplastic protein consisting of 670 residues, the last 615 of which form the active form. Three main domains are found, with two thiamine pyrophosphate sandwiching a DHS-like NAD/FAD-binding domain. In SCOP assignment, these subunits are named d1yhya1, d1yhya2, and d1yhya3 from the N-terminal to the C-terminal. The structure of acetolactate synthase that was used for the picture on this page was determined using X-ray diffraction at 2.70 angstroms. There are five specific ligands that interact with this protein. The five are listed below.
Sources: en.wikipedia.org
Aila Inkeri Keto AO (born 14 March 1943) is an Australian environmentalist. She is the founder and President of the Rainforest Conservation Society in Queensland, Australia, now known as the Australian Rainforest Conservation Society. In 2005, Keto was a recipient of the Queensland Greats Awards. Born in Tully, Queensland, Australia, to parents of Finnish origin, Dr Keto originally studied biochemistry and worked at the University of Queensland. In 1992, Keto received the IUCN Fred M. Packard Award in recognition of "outstanding service to protected and conserved areas" and in 1994 she was awarded an Officer of the Order of Australia for “service to conservation, particularly through promoting the protection and management of the wet tropical rainforests of Queensland”. She was nominated as Queenslander of the Year in 2000 and in 2001 she was awarded a Centenary Medal, "for service as an expert on wet tropics and as a leading conservationist and academic". In 2005, Dr Keto was awarded the Volvo Environment Prize for her work which, led to the protection of more than 15,000 square kilometres (5,800 sq mi) of Queensland's rainforest. This is only one of a series of awards that have been given to her for her environmental and conservation work which has resulted in three successful nominations for world heritage status: Wet Tropics, Fraser Island and the Central Eastern Rainforest Reserves of Australia (now Gondwana Rainforests of Australia).
The Huk movement was mainly spread in the central provinces of Nueva Ecija, Pampanga, Tarlac, Bulacan, and in Nueva Vizcaya, Pangasinan, Laguna, Bataan, and Quezon. An important movement in the campaign against the Huks was the deployment of hunter-killer counter guerrilla special units. The "Nenita" unit (1946–1949) was the first of such special forces whose main mission was to eliminate the Huks. The Nenita force was commanded by Major Napoleon Valeriano. The Nenita terror tactics which were not only committed against dissidents but also towards law-abiding people sometimes helped the Huks gain supporters as a consequence. In July 1950, Major Valeriano assumed command of the elite 7th Battalion Combat Team (BCT) in Bulacan. The 7th BCT would develop a reputation toward employing a more comprehensive, more unconventional counterinsurgency strategy and reduced the random brutality against the civilian population.
The marsupial thylacine (Tasmanian tiger or Tasmanian wolf) had many resemblances to placental canids. Several mammal groups have independently evolved prickly protrusions of the skin – echidnas (monotremes), the insectivorous hedgehogs, some tenrecs (a diverse group of shrew-like Malagasy mammals), Old World porcupines (rodents) and New World porcupines (another biological family of rodents). In this case, because the two groups of porcupines are closely related, they would be considered to be examples of parallel evolution; however, neither echidnas, nor hedgehogs, nor tenrecs are close relatives of the Rodentia. In fact, the last common ancestor of all of these groups lived in the age of the dinosaurs. The eutriconodont Spinolestes that lived in the Early Cretaceous Period represents an even earlier example of a spiny mammal, unrelated to any modern mammal group. Catlike sabre-toothed predators evolved in three distinct lineages of mammals – carnivorans like the sabre-toothed cats, and nimravids ("false" sabre-tooths), the sparassodont family Thylacosmilidae ("marsupial" sabre-tooths), the gorgonopsids and the creodonts also developed long canine teeth, but with no other particular physical similarities. A number of mammals have developed powerful fore claws and long, sticky tongues that allow them to open the homes of social insects (e.g., ants and termites) and consume them (myrmecophagy).
Furthermore, NASA gathered and published data indicating a significant heat signature at the military base, suggesting that a sizeable fire had erupted at the site overnight. In Kandahar, Pakistani officials released aerial footage of a large explosion at an ammunition depot near Kandahar International Airport (KDH). BBC News, using satellite imagery, confirmed the location of an ammunition depot in Kandahar. In Paktika, a video shared on social media showed smoke rising from a Taliban military base in the Urgun District. BBC News confirmed the location by matching roads and a distinctive foreground building with satellite imagery. Analysts at Maiar, an intelligence firm, stated that Pakistan's strikes on buildings and other infrastructure in Afghanistan appeared to be largely confined to military sites. They said that one of the buildings struck in Kabul appeared to be a military headquarters or command-and-control centre, and that vehicles parked nearby suggested the building had been occupied. In Kandahar, the analysts reported damage to at least two buildings within a large complex, which they assessed to be a headquarters of some kind. PAF airstrikes in Kandahar province also struck the former home of Mullah Omar, the late founder of the Taliban, which was currently serving as a base for the Taliban's suicide unit. The property is located about one kilometer from the residence of the current Taliban leader, Hibatullah Akhundzada. According to local Afghan sources, about 15 Taliban members were killed in the strike.
Sources: en.wikipedia.org
Two structural features of β-lactam antibiotics have been correlated with their antibiotic potency. The first is known as "Woodward's parameter", h, and is the height (in angstroms) of the pyramid formed by the nitrogen atom of the β-lactam as the apex and the three adjacent carbon atoms as the base. The second is called "Cohen's parameter", c, and is the distance between the carbon atom of the carboxylate and the oxygen atom of the β-lactam carbonyl. This distance is thought to correspond to the distance between the carboxylate-binding site and the oxyanion hole of the PBP enzyme. The best antibiotics are those with higher h values (more reactive to hydrolysis) and lower c values (better binding to PBPs).
Eventually, both Manlu and Zhu feel remorse of their misdeeds toward Manzhen, and Manlu begs her sister to come back to raise her nephew/stepson with her husband after they locate her, asking for forgiveness before she dies. Despite still hating them for the rape, Manzhen stays with Zhu for the sake of their son. By chance, Manzhen and Shijun reunite in Shanghai, and both talk of each other's lives years after their separation. Knowing that they still love each other, but due to the restrictions of their respective obligations, both Manzhen and Shijun realize that they cannot be together.
== History == The US Food and Drug Administration (FDA) approved bexagliflozin based on evidence from nine clinical trials that enrolled 4,462 adults (2,578 of these participants received bexagliflozin). The nine trials were conducted at 428 sites in 16 countries including the United States, Mexico, Colombia, Japan, the Czech Republic, Poland, Spain, Hungary, France, Canada, Netherlands, Denmark, South Korea, Taiwan, Russia, and Germany. All nine trials were used to assess safety and six of these trials (enrolling 3,346 participants of the 4,462 participants) were used to assess the efficacy of bexagliflozin. The efficacy of bexagliflozin was evaluated in six clinical trials, while the safety of bexagliflozin was evaluated in nine clinical trials of adults with type 2 diabetes whose blood sugar was not well controlled. All participants were required to follow diet and exercise recommendations, but the trials differed with respect to which other drugs participants were allowed to use for diabetes treatment. In four trials, participants were randomly assigned to receive either bexagliflozin or placebo by mouth once daily. In two trials, they received either bexagliflozin or a different diabetes medicine. Neither the participants nor the healthcare providers knew which treatment participants received until after the trial was completed. The benefit of bexagliflozin was evaluated by the change in hemoglobin A1c (HbA1c) between the bexagliflozin and the comparator (either placebo or another diabetes medicine) at the end of the treatment period.
Sources: en.wikipedia.org
Legality depends on the country and the intended use. In many places it is sold as a research chemical, but sports and medicine regulations restrict it.
Detection commonly uses liquid chromatography–tandem mass spectrometry. This method can identify the compound in urine or blood at low concentrations.
Typical guidance is −20 °C, dry, and protected from light. Solutions should be aliquoted and limited freeze–thaw cycles should be used.
It is a synthetic compound that acts as an agonist at REV-ERBα and REV-ERBβ. It is used mainly as a research chemical to study circadian and metabolic pathways. It is not approved for human therapeutic use.